Struggling to get a universal meningococcal vaccine and novel uses for bacterial toxins in cancer treatment.
Structural Proteomics in Toronto, UHN and University of Toronto, Banting and Best Department of Medical Research, C.H. Best Institute, 112 College Street, M5G 1L6, Toronto, Ontario, Canada.
Craig
C
Daniels
Tino
T
Krell
Carmen
C
Michán
Juan L
JL
Ramos
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001709:Biotechnology / Q000379:methods*; D003141:Communicable Diseases / Q000175:diagnosis*; D006801:Humans; D022401:Meningococcal Vaccines / Q000235:genetics / Q000276:immunology*; D046228:Microarray Analysis / Q000379:methods*; D030781:Organisms, Genetically Modified; D022621:Shiga Toxin / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D022401:Meningococcal Vaccines; D022621:Shiga Toxin
Int J Cancer. 1990 Jun 15;45(6):1040-4
1693599
Int J Syst Bacteriol. 1996 Apr;46(2):506-11
8934907
Microb Biotechnol. 2009 Nov;2(6):634-41
21255298
Microb Biotechnol. 2010 Jul;3(4):444-54
21255342
Blood. 1999 Oct 15;94(8):2901-10
10515895
Microb Biotechnol. 2011 Jan;4(1):32-46
21255370
Microb Biotechnol. 2010 Nov;3(6):634-57
21255361
Microb Biotechnol. 2010 Jan;3(1):10-4
21255301
Microb Biotechnol. 2011 Jan;4(1):20-31
21255369
Science. 1983 Apr 29;220(4596):509-11
6836295